Novel Methods to Evaluate the Cardiac Activity of Pharmaceuticals: Identifying New Therapies and Predicting Cardiac Toxicity

评估药物心脏活性的新方法：识别新疗法并预测心脏毒性

• 批准号: 337129
• 负责人: Maynes Jason T
• 金额: $ 26.04万
• 依托单位: Hospital for Sick Children (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2015
• 资助国家: 加拿大
• 起止时间: 2015-10-01 至 2018-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=337129&lang=en
• 关键词: 1101 Human Health; 1102 Biomedical Engineering; 1901 Biomedical Technology; 6404 Pharmacology; Carbon Nanotube; Cardiology; Drug Toxicity; Heart Failure; Stem Cell-Derived Tissue

Heart failure is the leading cause of death and disability within Canada, creating significant medical and socioeconomic costs. Developing new therapies for heart failure is challenging, primarily because we do not have good ways to model the action of he

心力衰竭是加拿大死亡和残疾的主要原因，造成巨大的医疗和社会经济成本。开发治疗心力衰竭的新疗法具有挑战性，主要是因为我们没有好的方法来模拟心力衰竭的作用。